Optimer Pharmaceuticals, Inc.
🏢 View company profile →16Patents
14Active
16Granted
48Portfolio score
Filing activity: Jul 15, 2003 → Mar 15, 2013 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7601695B2 | Antibacterial agents | Chemistry; Metallurgy | 26 | Expired |
| US8012943B2 | Antibacterial agents | Chemistry; Metallurgy | 15 | Active |
| US7378508B2 | Polymorphic crystalline forms of tiacumicin B | Chemistry; Metallurgy | 14 | Active |
| US8343936B2 | Antibacterial agents | Chemistry; Metallurgy | 9 | Active |
| US7863249B2 | Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Chemistry; Metallurgy | 6 | Active |
| US7507564B2 | Tiacumicin production | Chemistry; Metallurgy | 6 | Expired |
| US8883986B2 | Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Chemistry; Metallurgy | 4 | Active |
| US8859510B2 | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Chemistry; Metallurgy | 4 | Active |
| US8445654B2 | Antibiotic macrocycle compounds and methods of manufacture and use thereof | Human Necessities | 3 | Active |
| US8728796B2 | Tiacumicin production | Chemistry; Metallurgy | 3 | Active |
| US8518899B2 | Macrocyclic polymorphs, compositions comprising such polymorphs and methods of use and manufacture thereof | Human Necessities | 3 | Active |
| US8044030B2 | Antibiotic macrocycle compounds and methods of manufacture and use thereof | Human Necessities | 2 | Active |
| US8916527B2 | Antibiotic macrocycle compounds and methods of manufacture and use thereof | Human Necessities | 1 | Active |
| US8586551B2 | 18-membered macrocycles and analogs thereof | Chemistry; Metallurgy | 1 | Active |
| US7906489B2 | 18-membered macrocycles and analogs thereof | Chemistry; Metallurgy | 1 | Active |
| US7414885B2 | Method and apparatus for reading data from a ferromagnetic memory cell | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.